Article
Generic versions of two popular urology drugs move closer to approval
The FDA granted tentative approval to generic versions of two popular urology drugs, one for BPH and the other for overactive bladder.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera’s SNM device
Ashley Winter, MD, calls for label update on low-dose vaginal estrogen
The ADVANCED-2 trial, TARA-002
Unmet needs in high risk NMIBC
Joseph Song, MD, on the emergence of new suction-based devices for stone disease
How eating disorders affect bladder and pelvic floor health
Fitting Oral ADT Options Into the Prostate Cancer Treatment Plans
The Current Landscape of ADT in Prostate Cancer
Daniel D. Joyce, MD, MS, discusses the economics of trimodal therapy in MIBC
Sarah Razavi, MD, outlines strategies for mitigate surgeon discomfort during URS
Related Content
